Stifel Canada analysts adjusted their stance on Medexus Pharma (MDP:CN) (OTC: PDDPF), downgrading the stock rating from Buy to Hold and reducing the price target to Cdn$3.45 from the previous Cdn$6.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback